Silicon Valley’S Subsequent Large Health Investor

Silicon Valley’s medical technology start-ups might have their pick of local investors, but many are now looking further afield to China.
The goal for the partnership is to merge various forms of health data, like genomics and patient-reported symptoms, with AI to further our understanding of human disease.
In recent years, Tencent has funded a slew of U.S. bio-technology and digital health ventures.
Tencent led a $155 million round in health and artificial intelligence company iCarbonX, which subsequently secured a $100 million deal with the U.S.-based patient social networking company PatientsLikeMe.
One of the most prolific recent funders on the block is Tencent, the Shenzhen-based Internet giant that is best known for its social messaging apps.

Read more on: